Zobrazeno 1 - 10
of 318
pro vyhledávání: '"Erich Kohler"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. Marshall
Publikováno v:
French Studies. 41:69-69
Autor:
W. Rothwell
Publikováno v:
French Studies. 31:437-437
Autor:
W. Rothwell
Publikováno v:
French Studies. 36:460-460
Autor:
F. Venturi
Publikováno v:
French Studies. 10:266-266
Publikováno v:
Sante mentale au Quebec. 40(4)
Objectives Within the Quebec context, as well as the larger Canadian and International context, increasing access to mental health care treatment has become a major health care priority (see Peachey, Hicks,Adams, 2013). Initiatives to increase access
Publikováno v:
Archives of Drug Information. 4:33-41
Introduction. Recombinant human erythropoietin (r-HuEPO) is used to treat symptomatic anaemia due to chemotherapy. A new r-HuEPO, Epoetin theta (Eporatio®), was investigated and compared to placebo in a randomised, double-blind clinical trial in adu
Publikováno v:
Archives of Drug Information. 3:45-53
INTRODUCTION: Recombinant human erythropoietin (r-HuEPO) is used to treat symptomatic anaemia due to chemotherapy. A new r-HuEPO, Epoetin theta (Eporatio®), was investigated and compared to placebo and Epoetin beta in a randomised, double-blind clin
Autor:
Sergei A, Tjulandin, Peter, Bias, Reiner, Elsässer, Beate, Gertz, Erich, Kohler, Anton, Buchner
Publikováno v:
Archives of Drug Information
INTRODUCTION: Recombinant human erythropoietin (r-HuEPO) is used to treat symptomatic anaemia due to chemotherapy. A new r-HuEPO, Epoetin theta (Eporatio®), was investigated and compared to placebo in a randomised, double-blind clinical trial in adu
Autor:
Sergei A, Tjulandin, Peter, Bias, Reiner, Elsässer, Beate, Gertz, Erich, Kohler, Anton, Buchner
Publikováno v:
Archives of Drug Information
Introduction Recombinant human erythropoietin (r-HuEPO) is used to treat symptomatic anaemia due to chemotherapy. A new r-HuEPO, Epoetin theta (Eporatio®), was investigated and compared to placebo and Epoetin beta in a randomised, double-blind clini